The national FIT-based colorectal cancer screening program in the Netherlands during the COVID-19 pandemic

The COVID-19 pandemic has affected many healthcare services worldwide. Like many other nations, the Netherlands experienced large numbers of individuals affected by COVID-19 in 2020, leading to increased demands on hospitals and intensive care units. The Dutch Ministry of Health decided to suspend t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Preventive medicine 2021-10, Vol.151, p.106643-106643, Article 106643
Hauptverfasser: Kortlever, Tim L., de Jonge, Lucie, Wisse, Pieter H.A., Seriese, Iris, Otto-Terlouw, Patricia, van Leerdam, Monique E., Spaander, Manon C.W., Dekker, Evelien, Lansdorp-Vogelaar, Iris
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The COVID-19 pandemic has affected many healthcare services worldwide. Like many other nations, the Netherlands experienced large numbers of individuals affected by COVID-19 in 2020, leading to increased demands on hospitals and intensive care units. The Dutch Ministry of Health decided to suspend the Dutch biennial fecal immunochemical test (FIT) based colorectal cancer (CRC) screening program from March 16, 2020. FIT invitations were resumed on June 3. In this study, we describe the short-term effects of this suspension on a myriad of relevant screening outcomes. As a result of the suspension, a quarter of the individuals due for screening between March and November 2020 had not received their invitation for FIT screening by November 30, 2020. Furthermore, 57.8% of those who received a consecutive FIT between the restart and November 30, 2020, received it outside the upper limit of the standard screening interval (26 months). Median time between positive FIT and colonoscopy did not change as a result of the pandemic. Participation rates of FIT screening and follow-up colonoscopy in the months just before and during the suspension were significantly lower than expected, but returned to normal levels after the suspension. Based on the anticipated 2020 cohort size, we estimate that the number of individuals with advanced neoplasia currently detected up until November 2020 was 31.2% lower compared to what would have been expected without a pandemic. Future studies should monitor the impact on long-term screening outcomes as a result of the pandemic. •The Dutch CRC screening program suspended invitations for 11 weeks due to COVID-19•FIT participation decreased around the suspension, but recovered after the restart•After restart, FIT invitation interval was prolonged for 57.8% of repeat invitees•Median time between positive FIT and colonoscopy remained shorter than 30 days•Screen-detected diagnoses of AN decreased by 31% compared to the expected number
ISSN:0091-7435
1096-0260
1096-0260
DOI:10.1016/j.ypmed.2021.106643